Tarsus Pharmaceuticals
TARS
TARS
44 hedge funds and large institutions have $378M invested in Tarsus Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less capital invested
Capital invested by funds: $410M → $378M (-$31.8M)
Holders
44
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$14.9M | |
| 2 | +$12.8M | |
| 3 | +$6.8M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$4.93M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.44M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$13M | |
| 3 | -$7.47M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.8M |
| 5 |
Millennium Management
New York
|
-$2.73M |